Medtronic Wins $101 Million in Patent Case Against NuVasive
This article is for subscribers only.
Medtronic Inc. won a $101.2 million jury award in a patent-infringement trial against NuVasive Inc. over claims related to medical devices used in spinal surgery. NuVasive dropped as much as 8.4 percent in Nasdaq trading.
The federal jury in San Diego yesterday also held Medtronic liable for $660,000 in damages to NuVasive for infringing one of its patents.